Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 2, 2014 - Issue 1
Submit an article Journal homepage
153
Views
2
CrossRef citations to date
0
Altmetric
Drug Evaluations

The role of the farnesyltransferase inhibitor lonafarnib in the treatment of Progeria

Mark W KieranDirector of Pediatric Medical Neuro-Oncology, Dana-Farber Cancer Insitute, 450 Brookline Avenue, Rm D-3154, Boston MA 02215, USA+1 617 632 4907; +1 617 632 4897; [email protected];Boston Children’s Hospital, Pediatric Hematology/Oncology, 300 Longwood Avenue, USA
, MD PhD,
Leslie B GordonBoston Children's Hospital, Division of Critical Care Medicine, Department of Anesthesia, 300 Longwood Avenue, Boston MA 02115, USA;Warren Alpert Medical School of Brown University, Department of Pediatrics, Hasbro Children's Hospital, Providence, RI 02903, USA
, MD PhD &
Monica E KleinmanBoston Children's Hospital, Division of Critical Care Medicine, Department of Anesthesia, 300 Longwood Avenue, Boston MA 02115, USA
, MD
Pages 95-105 | Published online: 13 Dec 2013

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Audrey Gordon & Leslie Gordon. (2014) The Progeria Research Foundation: its remarkable journey from obscurity to treatment. Expert Opinion on Orphan Drugs 2:11, pages 1187-1195.
Read now

Articles from other publishers (1)

Shailima Rampogu, Ayoung Baek, Minky Son, Amir Zeb, Chanin Park, Raj Kumar, Gihwan Lee, Donghwan Kim, Yeonuk Choi, Yeongrae Cho, Yohan Park, Seok Ju Park & Keun Woo Lee. (2017) Computational Exploration for Lead Compounds That Can Reverse the Nuclear Morphology in Progeria. BioMed Research International 2017, pages 1-15.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.